Clinical Research Division, Fred Hutch
Dr. Diane Tseng is a clinical investigator who studies the interaction between lung cancer and the immune system with the goal of developing new lung cancer immunotherapy treatments. She studies how immune cells called T cells recognize tumor cells in the lungs. Her work examines immunotherapy biomarkers in lung cancer to understand mechanisms of response and resistance to treatment.
University of Washington School of Medicine, Department of Medicine, Division of Medical Oncology
Fred Hutchinson Cancer Center
2020: Fellowship, Medical Oncology, Stanford University School of Medicine
2016: Residency, Internal Medicine, Massachusetts General Hospital, Harvard University
2014: Internship, Internal Medicine, Massachusetts General Hospital, Harvard University
2013: M.D. Ph.D., Stanford University School of Medicine
2006: BS, Biological Sciences, Stanford University
Advancing immunotherapies for the treatment of lung cancer patients
Immunotherapy biomarkers of response in lung cancer
Mechanisms of T cell recruitment to non-small cell lung cancer
Head and neck cancers
— Dr. Diane Tseng
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email email@example.com or call 206.667.2210